nodes	percent_of_prediction	percent_of_DWPC	metapath
Ofloxacin—TOP2A—hematologic cancer	0.25	1	CbGaD
Ofloxacin—TOP2A—Idarubicin—hematologic cancer	0.0596	0.122	CbGbCtD
Ofloxacin—TOP2A—Daunorubicin—hematologic cancer	0.0422	0.086	CbGbCtD
Ofloxacin—TOP2A—Teniposide—hematologic cancer	0.0366	0.0748	CbGbCtD
Ofloxacin—ABCC1—Idarubicin—hematologic cancer	0.033	0.0674	CbGbCtD
Ofloxacin—TOP2A—Mitoxantrone—hematologic cancer	0.0256	0.0523	CbGbCtD
Ofloxacin—ABCC1—Daunorubicin—hematologic cancer	0.0234	0.0477	CbGbCtD
Ofloxacin—TOP2A—Epirubicin—hematologic cancer	0.0207	0.0423	CbGbCtD
Ofloxacin—ABCC2—Daunorubicin—hematologic cancer	0.0173	0.0353	CbGbCtD
Ofloxacin—TOP2A—Etoposide—hematologic cancer	0.0162	0.033	CbGbCtD
Ofloxacin—CYP1A2—Anagrelide—hematologic cancer	0.0159	0.0324	CbGbCtD
Ofloxacin—ABCC1—Mitoxantrone—hematologic cancer	0.0142	0.029	CbGbCtD
Ofloxacin—ABCC1—Epirubicin—hematologic cancer	0.0115	0.0235	CbGbCtD
Ofloxacin—ABCC1—Irinotecan—hematologic cancer	0.0112	0.0228	CbGbCtD
Ofloxacin—TOP2A—Doxorubicin—hematologic cancer	0.011	0.0225	CbGbCtD
Ofloxacin—ABCC1—Vinblastine—hematologic cancer	0.00994	0.0203	CbGbCtD
Ofloxacin—ABCC1—Vincristine—hematologic cancer	0.00977	0.0199	CbGbCtD
Ofloxacin—ABCC1—Etoposide—hematologic cancer	0.00896	0.0183	CbGbCtD
Ofloxacin—CYP1A2—Carmustine—hematologic cancer	0.00834	0.017	CbGbCtD
Ofloxacin—ABCC2—Irinotecan—hematologic cancer	0.00828	0.0169	CbGbCtD
Ofloxacin—ABCC2—Vinblastine—hematologic cancer	0.00736	0.015	CbGbCtD
Ofloxacin—ABCC2—Vincristine—hematologic cancer	0.00723	0.0148	CbGbCtD
Ofloxacin—CYP1A2—Methoxsalen—hematologic cancer	0.00709	0.0145	CbGbCtD
Ofloxacin—ABCC2—Cisplatin—hematologic cancer	0.00675	0.0138	CbGbCtD
Ofloxacin—CYP1A2—Bortezomib—hematologic cancer	0.00674	0.0138	CbGbCtD
Ofloxacin—ABCC2—Etoposide—hematologic cancer	0.00663	0.0135	CbGbCtD
Ofloxacin—CYP1A2—Daunorubicin—hematologic cancer	0.00645	0.0132	CbGbCtD
Ofloxacin—CYP1A2—Alitretinoin—hematologic cancer	0.00632	0.0129	CbGbCtD
Ofloxacin—ABCC1—Doxorubicin—hematologic cancer	0.00611	0.0125	CbGbCtD
Ofloxacin—ABCC1—Methotrexate—hematologic cancer	0.00592	0.0121	CbGbCtD
Ofloxacin—CYP1A2—Thalidomide—hematologic cancer	0.00587	0.012	CbGbCtD
Ofloxacin—ABCC2—Dexamethasone—hematologic cancer	0.00545	0.0111	CbGbCtD
Ofloxacin—CYP1A2—Dacarbazine—hematologic cancer	0.00505	0.0103	CbGbCtD
Ofloxacin—CYP1A2—Imatinib—hematologic cancer	0.00494	0.0101	CbGbCtD
Ofloxacin—ABCC2—Doxorubicin—hematologic cancer	0.00452	0.00923	CbGbCtD
Ofloxacin—ABCC2—Methotrexate—hematologic cancer	0.00438	0.00894	CbGbCtD
Ofloxacin—CYP1A2—Dasatinib—hematologic cancer	0.00397	0.0081	CbGbCtD
Ofloxacin—SLC22A6—Methotrexate—hematologic cancer	0.0032	0.00654	CbGbCtD
Ofloxacin—CYP1A2—Etoposide—hematologic cancer	0.00247	0.00504	CbGbCtD
Ofloxacin—Moxifloxacin—TOP2A—hematologic cancer	0.000554	0.182	CrCbGaD
Ofloxacin—TOP2A—blood—hematologic cancer	0.000408	0.0712	CbGeAlD
Ofloxacin—Pefloxacin—TOP2A—hematologic cancer	0.000404	0.133	CrCbGaD
Ofloxacin—TOP2A—bone marrow—hematologic cancer	0.000394	0.0689	CbGeAlD
Ofloxacin—Enoxacin—TOP2A—hematologic cancer	0.000378	0.124	CrCbGaD
Ofloxacin—TOP2A—lung—hematologic cancer	0.000357	0.0624	CbGeAlD
Ofloxacin—Sparfloxacin—TOP2A—hematologic cancer	0.000348	0.114	CrCbGaD
Ofloxacin—TOP2A—testis—hematologic cancer	0.000337	0.0589	CbGeAlD
Ofloxacin—SLC22A4—blood—hematologic cancer	0.000326	0.057	CbGeAlD
Ofloxacin—SLC22A4—bone marrow—hematologic cancer	0.000316	0.0551	CbGeAlD
Ofloxacin—CYP1A2—hematopoietic system—hematologic cancer	0.000295	0.0516	CbGeAlD
Ofloxacin—Lomefloxacin—TOP2A—hematologic cancer	0.000286	0.0941	CrCbGaD
Ofloxacin—SLC22A4—lung—hematologic cancer	0.000286	0.0499	CbGeAlD
Ofloxacin—ABCC2—blood—hematologic cancer	0.000279	0.0487	CbGeAlD
Ofloxacin—ABCC1—blood—hematologic cancer	0.000245	0.0429	CbGeAlD
Ofloxacin—Levofloxacin—TOP2A—hematologic cancer	0.000245	0.0804	CrCbGaD
Ofloxacin—TOP2A—lymph node—hematologic cancer	0.000244	0.0427	CbGeAlD
Ofloxacin—TOP2A—Nilotinib—Imatinib—hematologic cancer	0.000239	0.0778	CbGdCrCtD
Ofloxacin—Ciprofloxacin—TOP2A—hematologic cancer	0.000236	0.0777	CrCbGaD
Ofloxacin—ABCC2—testis—hematologic cancer	0.00023	0.0403	CbGeAlD
Ofloxacin—SLC22A5—blood—hematologic cancer	0.000216	0.0377	CbGeAlD
Ofloxacin—ABCC1—lung—hematologic cancer	0.000215	0.0376	CbGeAlD
Ofloxacin—ABCC1—testis—hematologic cancer	0.000203	0.0355	CbGeAlD
Ofloxacin—Norfloxacin—TOP2A—hematologic cancer	0.000198	0.0652	CrCbGaD
Ofloxacin—SLC22A4—lymph node—hematologic cancer	0.000196	0.0342	CbGeAlD
Ofloxacin—CYP1A2—blood—hematologic cancer	0.000196	0.0342	CbGeAlD
Ofloxacin—SLC22A5—lung—hematologic cancer	0.000189	0.0331	CbGeAlD
Ofloxacin—SLC22A5—testis—hematologic cancer	0.000179	0.0312	CbGeAlD
Ofloxacin—CYP1A2—lung—hematologic cancer	0.000171	0.0299	CbGeAlD
Ofloxacin—ABCC2—lymph node—hematologic cancer	0.000167	0.0292	CbGeAlD
Ofloxacin—Gatifloxacin—ALB—hematologic cancer	0.000159	0.0522	CrCbGaD
Ofloxacin—ABCC1—lymph node—hematologic cancer	0.000147	0.0257	CbGeAlD
Ofloxacin—TOP2A—Topotecan—Irinotecan—hematologic cancer	0.000132	0.0432	CbGdCrCtD
Ofloxacin—TOP2A—Etoposide—Teniposide—hematologic cancer	0.000132	0.0429	CbGdCrCtD
Ofloxacin—SLC22A5—lymph node—hematologic cancer	0.000129	0.0226	CbGeAlD
Ofloxacin—TOP2A—Vindesine—Vinorelbine—hematologic cancer	0.000118	0.0386	CbGdCrCtD
Ofloxacin—TOP2A—Podofilox—Teniposide—hematologic cancer	0.0001	0.0327	CbGdCrCtD
Ofloxacin—Sparfloxacin—ABCB1—hematologic cancer	9.89e-05	0.0325	CrCbGaD
Ofloxacin—TOP2A—Vindesine—Vinblastine—hematologic cancer	9.46e-05	0.0308	CbGdCrCtD
Ofloxacin—TOP2A—Vindesine—Vincristine—hematologic cancer	9.46e-05	0.0308	CbGdCrCtD
Ofloxacin—TOP2A—Floxuridine—Pentostatin—hematologic cancer	9.12e-05	0.0297	CbGdCrCtD
Ofloxacin—TOP2A—Doxorubicin—Daunorubicin—hematologic cancer	8.94e-05	0.0291	CbGdCrCtD
Ofloxacin—TOP2A—Epirubicin—Daunorubicin—hematologic cancer	8.94e-05	0.0291	CbGdCrCtD
Ofloxacin—TOP2A—Idarubicin—Daunorubicin—hematologic cancer	8.94e-05	0.0291	CbGdCrCtD
Ofloxacin—TOP2A—Menadione—Thalidomide—hematologic cancer	7.6e-05	0.0248	CbGdCrCtD
Ofloxacin—Levofloxacin—ABCB1—hematologic cancer	6.96e-05	0.0229	CrCbGaD
Ofloxacin—TOP2A—Cladribine—Pentostatin—hematologic cancer	6.91e-05	0.0225	CbGdCrCtD
Ofloxacin—TOP2A—Epirubicin—Idarubicin—hematologic cancer	6.78e-05	0.0221	CbGdCrCtD
Ofloxacin—TOP2A—Doxorubicin—Idarubicin—hematologic cancer	6.78e-05	0.0221	CbGdCrCtD
Ofloxacin—TOP2A—Daunorubicin—Idarubicin—hematologic cancer	6.78e-05	0.0221	CbGdCrCtD
Ofloxacin—Ciprofloxacin—ABCB1—hematologic cancer	6.72e-05	0.0221	CrCbGaD
Ofloxacin—TOP2A—Vincristine—Vinorelbine—hematologic cancer	6.39e-05	0.0208	CbGdCrCtD
Ofloxacin—TOP2A—Cladribine—Clofarabine—hematologic cancer	6.16e-05	0.0201	CbGdCrCtD
Ofloxacin—TOP2A—Vinorelbine—Vincristine—hematologic cancer	5.97e-05	0.0195	CbGdCrCtD
Ofloxacin—TOP2A—Vinorelbine—Vinblastine—hematologic cancer	5.97e-05	0.0195	CbGdCrCtD
Ofloxacin—TOP2A—Teniposide—Etoposide—hematologic cancer	5.97e-05	0.0194	CbGdCrCtD
Ofloxacin—TOP2A—Podofilox—Etoposide—hematologic cancer	5.97e-05	0.0194	CbGdCrCtD
Ofloxacin—TOP2A—Cladribine—Nelarabine—hematologic cancer	5.79e-05	0.0189	CbGdCrCtD
Ofloxacin—TOP2A—Floxuridine—Cladribine—hematologic cancer	5.49e-05	0.0179	CbGdCrCtD
Ofloxacin—TOP2A—Clofarabine—Nelarabine—hematologic cancer	5.35e-05	0.0174	CbGdCrCtD
Ofloxacin—TOP2A—Vinblastine—Vinorelbine—hematologic cancer	5.14e-05	0.0167	CbGdCrCtD
Ofloxacin—TOP2A—Vincristine—Vinblastine—hematologic cancer	5.11e-05	0.0166	CbGdCrCtD
Ofloxacin—TOP2A—Cytarabine—Clofarabine—hematologic cancer	4.84e-05	0.0158	CbGdCrCtD
Ofloxacin—TOP2A—Cytarabine—Nelarabine—hematologic cancer	4.55e-05	0.0148	CbGdCrCtD
Ofloxacin—TOP2A—Cladribine—Fludarabine—hematologic cancer	4.52e-05	0.0147	CbGdCrCtD
Ofloxacin—TOP2A—Clofarabine—Fludarabine—hematologic cancer	4.18e-05	0.0136	CbGdCrCtD
Ofloxacin—TOP2A—Vinblastine—Vincristine—hematologic cancer	4.11e-05	0.0134	CbGdCrCtD
Ofloxacin—TOP2A—Clofarabine—Cytarabine—hematologic cancer	3.94e-05	0.0129	CbGdCrCtD
Ofloxacin—TOP2A—Azacitidine—Pentostatin—hematologic cancer	3.89e-05	0.0127	CbGdCrCtD
Ofloxacin—TOP2A—Clofarabine—Cladribine—hematologic cancer	3.84e-05	0.0125	CbGdCrCtD
Ofloxacin—TOP2A—Gemcitabine—Cytarabine—hematologic cancer	3.65e-05	0.0119	CbGdCrCtD
Ofloxacin—TOP2A—Cytarabine—Fludarabine—hematologic cancer	3.55e-05	0.0116	CbGdCrCtD
Ofloxacin—TOP2A—Azacitidine—Clofarabine—hematologic cancer	3.47e-05	0.0113	CbGdCrCtD
Ofloxacin—TOP2A—Cytarabine—Gemcitabine—hematologic cancer	3.36e-05	0.0109	CbGdCrCtD
Ofloxacin—TOP2A—Azacitidine—Nelarabine—hematologic cancer	3.26e-05	0.0106	CbGdCrCtD
Ofloxacin—TOP2A—Doxorubicin—Epirubicin—hematologic cancer	3.11e-05	0.0101	CbGdCrCtD
Ofloxacin—TOP2A—Daunorubicin—Epirubicin—hematologic cancer	3.11e-05	0.0101	CbGdCrCtD
Ofloxacin—TOP2A—Idarubicin—Epirubicin—hematologic cancer	3.11e-05	0.0101	CbGdCrCtD
Ofloxacin—TOP2A—Daunorubicin—Doxorubicin—hematologic cancer	2.88e-05	0.00938	CbGdCrCtD
Ofloxacin—TOP2A—Epirubicin—Doxorubicin—hematologic cancer	2.88e-05	0.00938	CbGdCrCtD
Ofloxacin—TOP2A—Idarubicin—Doxorubicin—hematologic cancer	2.88e-05	0.00938	CbGdCrCtD
Ofloxacin—TOP2A—Azacitidine—Fludarabine—hematologic cancer	2.55e-05	0.0083	CbGdCrCtD
Ofloxacin—TOP2A—Azacitidine—Gemcitabine—hematologic cancer	2.41e-05	0.00784	CbGdCrCtD
Ofloxacin—TOP2A—Azacitidine—Cytarabine—hematologic cancer	2.41e-05	0.00784	CbGdCrCtD
Ofloxacin—TOP2A—Azacitidine—Cladribine—hematologic cancer	2.34e-05	0.00764	CbGdCrCtD
Ofloxacin—TOP2A—Methyltestosterone—Prednisone—hematologic cancer	1.44e-05	0.00468	CbGdCrCtD
Ofloxacin—ABCC1—Disease—GSTO1—hematologic cancer	1.42e-05	0.000351	CbGpPWpGaD
Ofloxacin—CYP1A2—Biological oxidations—GSTP1—hematologic cancer	1.42e-05	0.000351	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—hematologic cancer	1.41e-05	0.00035	CbGpPWpGaD
Ofloxacin—TOP2A—Methyltestosterone—Prednisolone—hematologic cancer	1.4e-05	0.00457	CbGdCrCtD
Ofloxacin—CYP1A2—Metapathway biotransformation—GSTP1—hematologic cancer	1.4e-05	0.000346	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—IDH2—hematologic cancer	1.4e-05	0.000346	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—HMMR—hematologic cancer	1.4e-05	0.000346	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—AGO2—hematologic cancer	1.39e-05	0.000344	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—HDAC9—hematologic cancer	1.37e-05	0.00034	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—H3F3B—hematologic cancer	1.36e-05	0.000337	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—RB1—hematologic cancer	1.35e-05	0.000335	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.35e-05	0.000334	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—IL6—hematologic cancer	1.35e-05	0.000333	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2A—hematologic cancer	1.33e-05	0.000329	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.32e-05	0.000326	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ARNTL—hematologic cancer	1.31e-05	0.000325	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—NPM1—hematologic cancer	1.31e-05	0.000324	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.31e-05	0.000323	CbGpPWpGaD
Ofloxacin—CYP1A2—Biological oxidations—GSTM1—hematologic cancer	1.3e-05	0.000323	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	1.29e-05	0.00032	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.29e-05	0.00032	CbGpPWpGaD
Ofloxacin—CYP1A2—Metapathway biotransformation—GSTM1—hematologic cancer	1.29e-05	0.000318	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—FHL2—hematologic cancer	1.28e-05	0.000317	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CA9—hematologic cancer	1.28e-05	0.000316	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ACP5—hematologic cancer	1.28e-05	0.000316	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—NCOR2—hematologic cancer	1.26e-05	0.000312	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—FGF19—hematologic cancer	1.25e-05	0.00031	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—RPS14—hematologic cancer	1.24e-05	0.000308	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—DKK1—hematologic cancer	1.24e-05	0.000306	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—STAT5B—hematologic cancer	1.23e-05	0.000303	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—NUP98—hematologic cancer	1.23e-05	0.000303	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—IDH1—hematologic cancer	1.2e-05	0.000297	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—hematologic cancer	1.2e-05	0.000297	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CST3—hematologic cancer	1.2e-05	0.000296	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.19e-05	0.000296	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—CDKN2A—hematologic cancer	1.19e-05	0.000295	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—ADCY7—hematologic cancer	1.19e-05	0.000294	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—GSTO1—hematologic cancer	1.19e-05	0.000294	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ABCC3—hematologic cancer	1.19e-05	0.000294	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—TXN—hematologic cancer	1.19e-05	0.000294	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—NUP214—hematologic cancer	1.18e-05	0.000292	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1B—hematologic cancer	1.18e-05	0.000292	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—SPHK1—hematologic cancer	1.16e-05	0.000288	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—MTR—hematologic cancer	1.16e-05	0.000286	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—XIAP—hematologic cancer	1.16e-05	0.000286	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—MDM2—hematologic cancer	1.15e-05	0.000286	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—ENO2—hematologic cancer	1.13e-05	0.000281	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—SMARCA4—hematologic cancer	1.13e-05	0.000279	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—hematologic cancer	1.12e-05	0.000278	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ARNTL—hematologic cancer	1.12e-05	0.000277	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—ALB—hematologic cancer	1.12e-05	0.000277	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—UGT1A1—hematologic cancer	1.12e-05	0.000277	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1A—hematologic cancer	1.09e-05	0.000269	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—SLC22A1—hematologic cancer	1.09e-05	0.000269	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CRABP1—hematologic cancer	1.09e-05	0.000269	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PHYH—hematologic cancer	1.09e-05	0.000269	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GMPS—hematologic cancer	1.09e-05	0.000269	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—FTCD—hematologic cancer	1.09e-05	0.000269	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	1.08e-05	0.000266	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—SDC1—hematologic cancer	1.08e-05	0.000266	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ALOX5—hematologic cancer	1.06e-05	0.000262	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—CDKN1B—hematologic cancer	1.05e-05	0.000261	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—LCK—hematologic cancer	1.04e-05	0.000258	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—EP300—hematologic cancer	1.04e-05	0.000256	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—NUP98—hematologic cancer	1.03e-05	0.000254	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	1.03e-05	0.000254	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—H3F3A—hematologic cancer	1.02e-05	0.000253	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	1.01e-05	0.000251	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—CCND1—hematologic cancer	1.01e-05	0.000249	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—NCOA3—hematologic cancer	9.96e-06	0.000246	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ADCY7—hematologic cancer	9.96e-06	0.000246	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—SMPD3—hematologic cancer	9.95e-06	0.000246	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PRKCZ—hematologic cancer	9.93e-06	0.000246	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	9.92e-06	0.000245	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—NUP214—hematologic cancer	9.89e-06	0.000245	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	9.79e-06	0.000242	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CALR—hematologic cancer	9.75e-06	0.000241	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—CDKN1A—hematologic cancer	9.73e-06	0.000241	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—MTR—hematologic cancer	9.69e-06	0.00024	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ABCG2—hematologic cancer	9.69e-06	0.00024	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PARP1—hematologic cancer	9.59e-06	0.000237	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ENO2—hematologic cancer	9.5e-06	0.000235	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—FBXW7—hematologic cancer	9.43e-06	0.000233	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—MAPK3—hematologic cancer	9.28e-06	0.00023	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	9.27e-06	0.000229	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—EP300—hematologic cancer	9.26e-06	0.000229	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—HDAC2—hematologic cancer	9.25e-06	0.000229	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CXCR4—hematologic cancer	9.25e-06	0.000229	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—GSTT1—hematologic cancer	9.22e-06	0.000228	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CD44—hematologic cancer	9.15e-06	0.000226	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	9.08e-06	0.000225	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	9.04e-06	0.000224	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—MYC—hematologic cancer	9.02e-06	0.000223	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CBL—hematologic cancer	9.02e-06	0.000223	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—CREBBP—hematologic cancer	9.02e-06	0.000223	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—SDC1—hematologic cancer	9.01e-06	0.000223	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	8.73e-06	0.000216	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—B3GAT1—hematologic cancer	8.69e-06	0.000215	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ASNS—hematologic cancer	8.69e-06	0.000215	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—DCK—hematologic cancer	8.69e-06	0.000215	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	8.63e-06	0.000214	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	8.61e-06	0.000213	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—HSP90AA1—hematologic cancer	8.6e-06	0.000213	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	8.5e-06	0.00021	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	8.5e-06	0.00021	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—ALB—hematologic cancer	8.44e-06	0.000209	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—MAPK3—hematologic cancer	8.3e-06	0.000205	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—STAT1—hematologic cancer	8.29e-06	0.000205	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—HDC—hematologic cancer	8.24e-06	0.000204	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—ALB—hematologic cancer	8.17e-06	0.000202	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	8.13e-06	0.000201	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—ALB—hematologic cancer	8.08e-06	0.0002	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—MYC—hematologic cancer	8.07e-06	0.0002	CbGpPWpGaD
Ofloxacin—Feeling abnormal—Betamethasone—hematologic cancer	7.81e-06	3.76e-05	CcSEcCtD
Ofloxacin—Cardiac disorder—Doxorubicin—hematologic cancer	7.8e-06	3.75e-05	CcSEcCtD
Ofloxacin—Flushing—Doxorubicin—hematologic cancer	7.8e-06	3.75e-05	CcSEcCtD
Ofloxacin—Flatulence—Epirubicin—hematologic cancer	7.79e-06	3.75e-05	CcSEcCtD
Ofloxacin—ABCC1—Disease—GRB2—hematologic cancer	7.76e-06	0.000192	CbGpPWpGaD
Ofloxacin—Tension—Epirubicin—hematologic cancer	7.76e-06	3.73e-05	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Betamethasone—hematologic cancer	7.75e-06	3.73e-05	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Dexamethasone—hematologic cancer	7.75e-06	3.73e-05	CcSEcCtD
Ofloxacin—Dysgeusia—Epirubicin—hematologic cancer	7.74e-06	3.73e-05	CcSEcCtD
Ofloxacin—ABCC1—Disease—PDGFA—hematologic cancer	7.74e-06	0.000192	CbGpPWpGaD
Ofloxacin—Hypersensitivity—Triamcinolone—hematologic cancer	7.69e-06	3.7e-05	CcSEcCtD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	7.68e-06	0.00019	CbGpPWpGaD
Ofloxacin—Nervousness—Epirubicin—hematologic cancer	7.68e-06	3.7e-05	CcSEcCtD
Ofloxacin—ABCC1—Metabolism—CD44—hematologic cancer	7.66e-06	0.00019	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—NQO1—hematologic cancer	7.66e-06	0.00019	CbGpPWpGaD
Ofloxacin—Back pain—Epirubicin—hematologic cancer	7.65e-06	3.68e-05	CcSEcCtD
Ofloxacin—ABCC1—Disease—KITLG—hematologic cancer	7.63e-06	0.000189	CbGpPWpGaD
Ofloxacin—Angiopathy—Doxorubicin—hematologic cancer	7.62e-06	3.67e-05	CcSEcCtD
Ofloxacin—Malaise—Methotrexate—hematologic cancer	7.62e-06	3.67e-05	CcSEcCtD
Ofloxacin—Dizziness—Etoposide—hematologic cancer	7.61e-06	3.66e-05	CcSEcCtD
Ofloxacin—Muscle spasms—Epirubicin—hematologic cancer	7.6e-06	3.66e-05	CcSEcCtD
Ofloxacin—Immune system disorder—Doxorubicin—hematologic cancer	7.59e-06	3.65e-05	CcSEcCtD
Ofloxacin—Vertigo—Methotrexate—hematologic cancer	7.59e-06	3.65e-05	CcSEcCtD
Ofloxacin—Mediastinal disorder—Doxorubicin—hematologic cancer	7.57e-06	3.64e-05	CcSEcCtD
Ofloxacin—Leukopenia—Methotrexate—hematologic cancer	7.56e-06	3.64e-05	CcSEcCtD
Ofloxacin—Chills—Doxorubicin—hematologic cancer	7.54e-06	3.63e-05	CcSEcCtD
Ofloxacin—CYP1A2—Metabolism—CDA—hematologic cancer	7.54e-06	0.000186	CbGpPWpGaD
Ofloxacin—Urticaria—Dexamethasone—hematologic cancer	7.53e-06	3.62e-05	CcSEcCtD
Ofloxacin—Urticaria—Betamethasone—hematologic cancer	7.53e-06	3.62e-05	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Prednisone—hematologic cancer	7.52e-06	3.62e-05	CcSEcCtD
Ofloxacin—Dizziness—Prednisolone—hematologic cancer	7.51e-06	3.61e-05	CcSEcCtD
Ofloxacin—Arrhythmia—Doxorubicin—hematologic cancer	7.51e-06	3.61e-05	CcSEcCtD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	7.5e-06	0.000186	CbGpPWpGaD
Ofloxacin—Asthenia—Triamcinolone—hematologic cancer	7.49e-06	3.61e-05	CcSEcCtD
Ofloxacin—Body temperature increased—Dexamethasone—hematologic cancer	7.49e-06	3.6e-05	CcSEcCtD
Ofloxacin—Abdominal pain—Dexamethasone—hematologic cancer	7.49e-06	3.6e-05	CcSEcCtD
Ofloxacin—Abdominal pain—Betamethasone—hematologic cancer	7.49e-06	3.6e-05	CcSEcCtD
Ofloxacin—Body temperature increased—Betamethasone—hematologic cancer	7.49e-06	3.6e-05	CcSEcCtD
Ofloxacin—Nausea—Cisplatin—hematologic cancer	7.46e-06	3.59e-05	CcSEcCtD
Ofloxacin—Insomnia—Prednisone—hematologic cancer	7.46e-06	3.59e-05	CcSEcCtD
Ofloxacin—ABCC1—Disease—STAT5A—hematologic cancer	7.46e-06	0.000185	CbGpPWpGaD
Ofloxacin—Vision blurred—Epirubicin—hematologic cancer	7.45e-06	3.59e-05	CcSEcCtD
Ofloxacin—Alopecia—Doxorubicin—hematologic cancer	7.42e-06	3.57e-05	CcSEcCtD
Ofloxacin—Paraesthesia—Prednisone—hematologic cancer	7.41e-06	3.57e-05	CcSEcCtD
Ofloxacin—ABCC1—Disease—CDKN2B—hematologic cancer	7.39e-06	0.000183	CbGpPWpGaD
Ofloxacin—Pruritus—Triamcinolone—hematologic cancer	7.39e-06	3.55e-05	CcSEcCtD
Ofloxacin—Cough—Methotrexate—hematologic cancer	7.37e-06	3.55e-05	CcSEcCtD
Ofloxacin—Mental disorder—Doxorubicin—hematologic cancer	7.36e-06	3.54e-05	CcSEcCtD
Ofloxacin—Ill-defined disorder—Epirubicin—hematologic cancer	7.33e-06	3.53e-05	CcSEcCtD
Ofloxacin—Vomiting—Etoposide—hematologic cancer	7.32e-06	3.52e-05	CcSEcCtD
Ofloxacin—Malnutrition—Doxorubicin—hematologic cancer	7.31e-06	3.52e-05	CcSEcCtD
Ofloxacin—Erythema—Doxorubicin—hematologic cancer	7.31e-06	3.52e-05	CcSEcCtD
Ofloxacin—Anaemia—Epirubicin—hematologic cancer	7.31e-06	3.52e-05	CcSEcCtD
Ofloxacin—Agitation—Epirubicin—hematologic cancer	7.26e-06	3.5e-05	CcSEcCtD
Ofloxacin—Dyspepsia—Prednisone—hematologic cancer	7.26e-06	3.49e-05	CcSEcCtD
Ofloxacin—Rash—Etoposide—hematologic cancer	7.26e-06	3.49e-05	CcSEcCtD
Ofloxacin—CYP1A2—Metabolism—PC—hematologic cancer	7.26e-06	0.00018	CbGpPWpGaD
Ofloxacin—Dermatitis—Etoposide—hematologic cancer	7.25e-06	3.49e-05	CcSEcCtD
Ofloxacin—ABCC1—Metabolism—CYCS—hematologic cancer	7.25e-06	0.000179	CbGpPWpGaD
Ofloxacin—Headache—Etoposide—hematologic cancer	7.21e-06	3.47e-05	CcSEcCtD
Ofloxacin—Flatulence—Doxorubicin—hematologic cancer	7.21e-06	3.47e-05	CcSEcCtD
Ofloxacin—ABCC1—Metabolism—HSP90AA1—hematologic cancer	7.2e-06	0.000178	CbGpPWpGaD
Ofloxacin—Chest pain—Methotrexate—hematologic cancer	7.19e-06	3.46e-05	CcSEcCtD
Ofloxacin—Myalgia—Methotrexate—hematologic cancer	7.19e-06	3.46e-05	CcSEcCtD
Ofloxacin—Arthralgia—Methotrexate—hematologic cancer	7.19e-06	3.46e-05	CcSEcCtD
Ofloxacin—Tension—Doxorubicin—hematologic cancer	7.18e-06	3.45e-05	CcSEcCtD
Ofloxacin—Decreased appetite—Prednisone—hematologic cancer	7.17e-06	3.45e-05	CcSEcCtD
Ofloxacin—Dysgeusia—Doxorubicin—hematologic cancer	7.16e-06	3.45e-05	CcSEcCtD
Ofloxacin—Rash—Prednisolone—hematologic cancer	7.16e-06	3.45e-05	CcSEcCtD
Ofloxacin—Dermatitis—Prednisolone—hematologic cancer	7.15e-06	3.44e-05	CcSEcCtD
Ofloxacin—ABCC1—Disease—CD86—hematologic cancer	7.15e-06	0.000177	CbGpPWpGaD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	7.14e-06	3.44e-05	CcSEcCtD
Ofloxacin—Malaise—Epirubicin—hematologic cancer	7.13e-06	3.43e-05	CcSEcCtD
Ofloxacin—Fatigue—Prednisone—hematologic cancer	7.11e-06	3.42e-05	CcSEcCtD
Ofloxacin—Headache—Prednisolone—hematologic cancer	7.11e-06	3.42e-05	CcSEcCtD
Ofloxacin—Discomfort—Methotrexate—hematologic cancer	7.11e-06	3.42e-05	CcSEcCtD
Ofloxacin—Nervousness—Doxorubicin—hematologic cancer	7.1e-06	3.42e-05	CcSEcCtD
Ofloxacin—Vertigo—Epirubicin—hematologic cancer	7.1e-06	3.42e-05	CcSEcCtD
Ofloxacin—Syncope—Epirubicin—hematologic cancer	7.09e-06	3.41e-05	CcSEcCtD
Ofloxacin—Leukopenia—Epirubicin—hematologic cancer	7.08e-06	3.41e-05	CcSEcCtD
Ofloxacin—Back pain—Doxorubicin—hematologic cancer	7.08e-06	3.41e-05	CcSEcCtD
Ofloxacin—Constipation—Prednisone—hematologic cancer	7.05e-06	3.4e-05	CcSEcCtD
Ofloxacin—ABCC1—Disease—HES1—hematologic cancer	7.05e-06	0.000174	CbGpPWpGaD
Ofloxacin—Muscle spasms—Doxorubicin—hematologic cancer	7.03e-06	3.38e-05	CcSEcCtD
Ofloxacin—ABCC1—Disease—NCOR1—hematologic cancer	7.01e-06	0.000173	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—SLC35B2—hematologic cancer	7.01e-06	0.000173	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GBA—hematologic cancer	7.01e-06	0.000173	CbGpPWpGaD
Ofloxacin—Palpitations—Epirubicin—hematologic cancer	6.99e-06	3.36e-05	CcSEcCtD
Ofloxacin—Confusional state—Methotrexate—hematologic cancer	6.95e-06	3.35e-05	CcSEcCtD
Ofloxacin—Loss of consciousness—Epirubicin—hematologic cancer	6.95e-06	3.34e-05	CcSEcCtD
Ofloxacin—ABCC1—Disease—FGF1—hematologic cancer	6.93e-06	0.000172	CbGpPWpGaD
Ofloxacin—Dizziness—Triamcinolone—hematologic cancer	6.9e-06	3.32e-05	CcSEcCtD
Ofloxacin—Cough—Epirubicin—hematologic cancer	6.9e-06	3.32e-05	CcSEcCtD
Ofloxacin—Anaphylactic shock—Methotrexate—hematologic cancer	6.89e-06	3.32e-05	CcSEcCtD
Ofloxacin—Vision blurred—Doxorubicin—hematologic cancer	6.89e-06	3.32e-05	CcSEcCtD
Ofloxacin—Infection—Methotrexate—hematologic cancer	6.85e-06	3.3e-05	CcSEcCtD
Ofloxacin—Nausea—Etoposide—hematologic cancer	6.84e-06	3.29e-05	CcSEcCtD
Ofloxacin—ABCC1—Disease—FOXO1—hematologic cancer	6.83e-06	0.000169	CbGpPWpGaD
Ofloxacin—Hypertension—Epirubicin—hematologic cancer	6.83e-06	3.28e-05	CcSEcCtD
Ofloxacin—ABCC1—Disease—PDGFRB—hematologic cancer	6.82e-06	0.000169	CbGpPWpGaD
Ofloxacin—Feeling abnormal—Prednisone—hematologic cancer	6.8e-06	3.27e-05	CcSEcCtD
Ofloxacin—Asthenia—Dexamethasone—hematologic cancer	6.8e-06	3.27e-05	CcSEcCtD
Ofloxacin—Asthenia—Betamethasone—hematologic cancer	6.8e-06	3.27e-05	CcSEcCtD
Ofloxacin—Ill-defined disorder—Doxorubicin—hematologic cancer	6.79e-06	3.27e-05	CcSEcCtD
Ofloxacin—Nervous system disorder—Methotrexate—hematologic cancer	6.76e-06	3.25e-05	CcSEcCtD
Ofloxacin—Anaemia—Doxorubicin—hematologic cancer	6.76e-06	3.25e-05	CcSEcCtD
Ofloxacin—Thrombocytopenia—Methotrexate—hematologic cancer	6.75e-06	3.25e-05	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Prednisone—hematologic cancer	6.75e-06	3.25e-05	CcSEcCtD
Ofloxacin—Nausea—Prednisolone—hematologic cancer	6.74e-06	3.25e-05	CcSEcCtD
Ofloxacin—Myalgia—Epirubicin—hematologic cancer	6.73e-06	3.24e-05	CcSEcCtD
Ofloxacin—Chest pain—Epirubicin—hematologic cancer	6.73e-06	3.24e-05	CcSEcCtD
Ofloxacin—Arthralgia—Epirubicin—hematologic cancer	6.73e-06	3.24e-05	CcSEcCtD
Ofloxacin—Agitation—Doxorubicin—hematologic cancer	6.72e-06	3.24e-05	CcSEcCtD
Ofloxacin—ABCC1—Disease—PDGFRA—hematologic cancer	6.71e-06	0.000166	CbGpPWpGaD
Ofloxacin—Anxiety—Epirubicin—hematologic cancer	6.71e-06	3.23e-05	CcSEcCtD
Ofloxacin—Pruritus—Betamethasone—hematologic cancer	6.7e-06	3.23e-05	CcSEcCtD
Ofloxacin—Pruritus—Dexamethasone—hematologic cancer	6.7e-06	3.23e-05	CcSEcCtD
Ofloxacin—Skin disorder—Methotrexate—hematologic cancer	6.7e-06	3.22e-05	CcSEcCtD
Ofloxacin—ABCC1—Disease—JAK1—hematologic cancer	6.69e-06	0.000166	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PRKCG—hematologic cancer	6.69e-06	0.000166	CbGpPWpGaD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	6.68e-06	3.22e-05	CcSEcCtD
Ofloxacin—Hyperhidrosis—Methotrexate—hematologic cancer	6.66e-06	3.21e-05	CcSEcCtD
Ofloxacin—Discomfort—Epirubicin—hematologic cancer	6.65e-06	3.2e-05	CcSEcCtD
Ofloxacin—Vomiting—Triamcinolone—hematologic cancer	6.64e-06	3.19e-05	CcSEcCtD
Ofloxacin—TOP2A—Cell Cycle—TP53—hematologic cancer	6.63e-06	0.000164	CbGpPWpGaD
Ofloxacin—Malaise—Doxorubicin—hematologic cancer	6.6e-06	3.17e-05	CcSEcCtD
Ofloxacin—Rash—Triamcinolone—hematologic cancer	6.58e-06	3.17e-05	CcSEcCtD
Ofloxacin—Dry mouth—Epirubicin—hematologic cancer	6.58e-06	3.17e-05	CcSEcCtD
Ofloxacin—Dermatitis—Triamcinolone—hematologic cancer	6.58e-06	3.17e-05	CcSEcCtD
Ofloxacin—Vertigo—Doxorubicin—hematologic cancer	6.57e-06	3.16e-05	CcSEcCtD
Ofloxacin—Anorexia—Methotrexate—hematologic cancer	6.57e-06	3.16e-05	CcSEcCtD
Ofloxacin—Syncope—Doxorubicin—hematologic cancer	6.56e-06	3.16e-05	CcSEcCtD
Ofloxacin—Urticaria—Prednisone—hematologic cancer	6.55e-06	3.15e-05	CcSEcCtD
Ofloxacin—Leukopenia—Doxorubicin—hematologic cancer	6.55e-06	3.15e-05	CcSEcCtD
Ofloxacin—Headache—Triamcinolone—hematologic cancer	6.54e-06	3.15e-05	CcSEcCtD
Ofloxacin—Abdominal pain—Prednisone—hematologic cancer	6.52e-06	3.14e-05	CcSEcCtD
Ofloxacin—Body temperature increased—Prednisone—hematologic cancer	6.52e-06	3.14e-05	CcSEcCtD
Ofloxacin—Confusional state—Epirubicin—hematologic cancer	6.51e-06	3.13e-05	CcSEcCtD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	6.48e-06	0.00016	CbGpPWpGaD
Ofloxacin—Diarrhoea—Dexamethasone—hematologic cancer	6.48e-06	3.12e-05	CcSEcCtD
Ofloxacin—Diarrhoea—Betamethasone—hematologic cancer	6.48e-06	3.12e-05	CcSEcCtD
Ofloxacin—Palpitations—Doxorubicin—hematologic cancer	6.46e-06	3.11e-05	CcSEcCtD
Ofloxacin—Oedema—Epirubicin—hematologic cancer	6.45e-06	3.11e-05	CcSEcCtD
Ofloxacin—Anaphylactic shock—Epirubicin—hematologic cancer	6.45e-06	3.11e-05	CcSEcCtD
Ofloxacin—Hypotension—Methotrexate—hematologic cancer	6.44e-06	3.1e-05	CcSEcCtD
Ofloxacin—Loss of consciousness—Doxorubicin—hematologic cancer	6.43e-06	3.09e-05	CcSEcCtD
Ofloxacin—Infection—Epirubicin—hematologic cancer	6.41e-06	3.08e-05	CcSEcCtD
Ofloxacin—CYP1A2—Metabolism—MTAP—hematologic cancer	6.41e-06	0.000159	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—GSTP1—hematologic cancer	6.39e-06	0.000158	CbGpPWpGaD
Ofloxacin—Cough—Doxorubicin—hematologic cancer	6.38e-06	3.07e-05	CcSEcCtD
Ofloxacin—Shock—Epirubicin—hematologic cancer	6.35e-06	3.06e-05	CcSEcCtD
Ofloxacin—Nervous system disorder—Epirubicin—hematologic cancer	6.33e-06	3.05e-05	CcSEcCtD
Ofloxacin—Thrombocytopenia—Epirubicin—hematologic cancer	6.32e-06	3.04e-05	CcSEcCtD
Ofloxacin—Hypertension—Doxorubicin—hematologic cancer	6.32e-06	3.04e-05	CcSEcCtD
Ofloxacin—Tachycardia—Epirubicin—hematologic cancer	6.3e-06	3.03e-05	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Methotrexate—hematologic cancer	6.28e-06	3.02e-05	CcSEcCtD
Ofloxacin—Skin disorder—Epirubicin—hematologic cancer	6.27e-06	3.02e-05	CcSEcCtD
Ofloxacin—Dizziness—Dexamethasone—hematologic cancer	6.26e-06	3.01e-05	CcSEcCtD
Ofloxacin—Dizziness—Betamethasone—hematologic cancer	6.26e-06	3.01e-05	CcSEcCtD
Ofloxacin—Hyperhidrosis—Epirubicin—hematologic cancer	6.24e-06	3e-05	CcSEcCtD
Ofloxacin—Insomnia—Methotrexate—hematologic cancer	6.24e-06	3e-05	CcSEcCtD
Ofloxacin—Chest pain—Doxorubicin—hematologic cancer	6.23e-06	3e-05	CcSEcCtD
Ofloxacin—Arthralgia—Doxorubicin—hematologic cancer	6.23e-06	3e-05	CcSEcCtD
Ofloxacin—Myalgia—Doxorubicin—hematologic cancer	6.23e-06	3e-05	CcSEcCtD
Ofloxacin—Anxiety—Doxorubicin—hematologic cancer	6.21e-06	2.99e-05	CcSEcCtD
Ofloxacin—Nausea—Triamcinolone—hematologic cancer	6.2e-06	2.98e-05	CcSEcCtD
Ofloxacin—ABCC1—Disease—MTHFR—hematologic cancer	6.2e-06	0.000153	CbGpPWpGaD
Ofloxacin—Paraesthesia—Methotrexate—hematologic cancer	6.19e-06	2.98e-05	CcSEcCtD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	6.18e-06	2.98e-05	CcSEcCtD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	6.18e-06	0.000153	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—TERT—hematologic cancer	6.18e-06	0.000153	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—HLA-A—hematologic cancer	6.18e-06	0.000153	CbGpPWpGaD
Ofloxacin—Discomfort—Doxorubicin—hematologic cancer	6.15e-06	2.96e-05	CcSEcCtD
Ofloxacin—Anorexia—Epirubicin—hematologic cancer	6.15e-06	2.96e-05	CcSEcCtD
Ofloxacin—Dyspnoea—Methotrexate—hematologic cancer	6.15e-06	2.96e-05	CcSEcCtD
Ofloxacin—Somnolence—Methotrexate—hematologic cancer	6.13e-06	2.95e-05	CcSEcCtD
Ofloxacin—Dry mouth—Doxorubicin—hematologic cancer	6.09e-06	2.93e-05	CcSEcCtD
Ofloxacin—Hypersensitivity—Prednisone—hematologic cancer	6.08e-06	2.93e-05	CcSEcCtD
Ofloxacin—Dyspepsia—Methotrexate—hematologic cancer	6.07e-06	2.92e-05	CcSEcCtD
Ofloxacin—ABCC1—Metabolism—ABCB1—hematologic cancer	6.05e-06	0.00015	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PDGFB—hematologic cancer	6.03e-06	0.000149	CbGpPWpGaD
Ofloxacin—Hypotension—Epirubicin—hematologic cancer	6.03e-06	2.9e-05	CcSEcCtD
Ofloxacin—Vomiting—Dexamethasone—hematologic cancer	6.02e-06	2.9e-05	CcSEcCtD
Ofloxacin—Vomiting—Betamethasone—hematologic cancer	6.02e-06	2.9e-05	CcSEcCtD
Ofloxacin—Confusional state—Doxorubicin—hematologic cancer	6.02e-06	2.9e-05	CcSEcCtD
Ofloxacin—Decreased appetite—Methotrexate—hematologic cancer	5.99e-06	2.88e-05	CcSEcCtD
Ofloxacin—Rash—Dexamethasone—hematologic cancer	5.97e-06	2.87e-05	CcSEcCtD
Ofloxacin—Rash—Betamethasone—hematologic cancer	5.97e-06	2.87e-05	CcSEcCtD
Ofloxacin—Oedema—Doxorubicin—hematologic cancer	5.97e-06	2.87e-05	CcSEcCtD
Ofloxacin—Anaphylactic shock—Doxorubicin—hematologic cancer	5.97e-06	2.87e-05	CcSEcCtD
Ofloxacin—Dermatitis—Betamethasone—hematologic cancer	5.97e-06	2.87e-05	CcSEcCtD
Ofloxacin—Dermatitis—Dexamethasone—hematologic cancer	5.97e-06	2.87e-05	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Methotrexate—hematologic cancer	5.95e-06	2.86e-05	CcSEcCtD
Ofloxacin—Fatigue—Methotrexate—hematologic cancer	5.94e-06	2.86e-05	CcSEcCtD
Ofloxacin—Headache—Dexamethasone—hematologic cancer	5.93e-06	2.86e-05	CcSEcCtD
Ofloxacin—Headache—Betamethasone—hematologic cancer	5.93e-06	2.86e-05	CcSEcCtD
Ofloxacin—Infection—Doxorubicin—hematologic cancer	5.93e-06	2.85e-05	CcSEcCtD
Ofloxacin—Asthenia—Prednisone—hematologic cancer	5.92e-06	2.85e-05	CcSEcCtD
Ofloxacin—Pain—Methotrexate—hematologic cancer	5.9e-06	2.84e-05	CcSEcCtD
Ofloxacin—ABCC1—Disease—TSC2—hematologic cancer	5.9e-06	0.000146	CbGpPWpGaD
Ofloxacin—Musculoskeletal discomfort—Epirubicin—hematologic cancer	5.88e-06	2.83e-05	CcSEcCtD
Ofloxacin—Shock—Doxorubicin—hematologic cancer	5.87e-06	2.83e-05	CcSEcCtD
Ofloxacin—ABCC1—Metabolism—GSTM1—hematologic cancer	5.87e-06	0.000145	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—NCOR1—hematologic cancer	5.87e-06	0.000145	CbGpPWpGaD
Ofloxacin—Nervous system disorder—Doxorubicin—hematologic cancer	5.85e-06	2.82e-05	CcSEcCtD
Ofloxacin—Thrombocytopenia—Doxorubicin—hematologic cancer	5.84e-06	2.81e-05	CcSEcCtD
Ofloxacin—Pruritus—Prednisone—hematologic cancer	5.84e-06	2.81e-05	CcSEcCtD
Ofloxacin—Insomnia—Epirubicin—hematologic cancer	5.84e-06	2.81e-05	CcSEcCtD
Ofloxacin—Tachycardia—Doxorubicin—hematologic cancer	5.83e-06	2.8e-05	CcSEcCtD
Ofloxacin—Skin disorder—Doxorubicin—hematologic cancer	5.8e-06	2.79e-05	CcSEcCtD
Ofloxacin—Paraesthesia—Epirubicin—hematologic cancer	5.79e-06	2.79e-05	CcSEcCtD
Ofloxacin—Hyperhidrosis—Doxorubicin—hematologic cancer	5.77e-06	2.78e-05	CcSEcCtD
Ofloxacin—Dyspnoea—Epirubicin—hematologic cancer	5.75e-06	2.77e-05	CcSEcCtD
Ofloxacin—Somnolence—Epirubicin—hematologic cancer	5.74e-06	2.76e-05	CcSEcCtD
Ofloxacin—CYP1A2—Metabolism—FHL2—hematologic cancer	5.71e-06	0.000141	CbGpPWpGaD
Ofloxacin—Anorexia—Doxorubicin—hematologic cancer	5.69e-06	2.74e-05	CcSEcCtD
Ofloxacin—Feeling abnormal—Methotrexate—hematologic cancer	5.68e-06	2.73e-05	CcSEcCtD
Ofloxacin—Dyspepsia—Epirubicin—hematologic cancer	5.68e-06	2.73e-05	CcSEcCtD
Ofloxacin—ABCC1—Disease—FGFR3—hematologic cancer	5.67e-06	0.00014	CbGpPWpGaD
Ofloxacin—Diarrhoea—Prednisone—hematologic cancer	5.64e-06	2.72e-05	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Methotrexate—hematologic cancer	5.64e-06	2.71e-05	CcSEcCtD
Ofloxacin—Nausea—Betamethasone—hematologic cancer	5.63e-06	2.71e-05	CcSEcCtD
Ofloxacin—Nausea—Dexamethasone—hematologic cancer	5.63e-06	2.71e-05	CcSEcCtD
Ofloxacin—Decreased appetite—Epirubicin—hematologic cancer	5.61e-06	2.7e-05	CcSEcCtD
Ofloxacin—CYP1A2—Metabolism—AGRN—hematologic cancer	5.6e-06	0.000139	CbGpPWpGaD
Ofloxacin—Hypotension—Doxorubicin—hematologic cancer	5.58e-06	2.68e-05	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Epirubicin—hematologic cancer	5.57e-06	2.68e-05	CcSEcCtD
Ofloxacin—Fatigue—Epirubicin—hematologic cancer	5.56e-06	2.68e-05	CcSEcCtD
Ofloxacin—Pain—Epirubicin—hematologic cancer	5.52e-06	2.66e-05	CcSEcCtD
Ofloxacin—Constipation—Epirubicin—hematologic cancer	5.52e-06	2.66e-05	CcSEcCtD
Ofloxacin—Urticaria—Methotrexate—hematologic cancer	5.48e-06	2.64e-05	CcSEcCtD
Ofloxacin—Dizziness—Prednisone—hematologic cancer	5.45e-06	2.63e-05	CcSEcCtD
Ofloxacin—Abdominal pain—Methotrexate—hematologic cancer	5.45e-06	2.62e-05	CcSEcCtD
Ofloxacin—Body temperature increased—Methotrexate—hematologic cancer	5.45e-06	2.62e-05	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	5.44e-06	2.62e-05	CcSEcCtD
Ofloxacin—Insomnia—Doxorubicin—hematologic cancer	5.4e-06	2.6e-05	CcSEcCtD
Ofloxacin—ABCC1—Disease—BAD—hematologic cancer	5.38e-06	0.000133	CbGpPWpGaD
Ofloxacin—Paraesthesia—Doxorubicin—hematologic cancer	5.36e-06	2.58e-05	CcSEcCtD
Ofloxacin—ABCC1—Disease—NOTCH1—hematologic cancer	5.32e-06	0.000132	CbGpPWpGaD
Ofloxacin—Dyspnoea—Doxorubicin—hematologic cancer	5.32e-06	2.56e-05	CcSEcCtD
Ofloxacin—Feeling abnormal—Epirubicin—hematologic cancer	5.32e-06	2.56e-05	CcSEcCtD
Ofloxacin—CYP1A2—Metabolism—IDH2—hematologic cancer	5.31e-06	0.000131	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—HMMR—hematologic cancer	5.31e-06	0.000131	CbGpPWpGaD
Ofloxacin—Somnolence—Doxorubicin—hematologic cancer	5.31e-06	2.55e-05	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Epirubicin—hematologic cancer	5.28e-06	2.54e-05	CcSEcCtD
Ofloxacin—Dyspepsia—Doxorubicin—hematologic cancer	5.25e-06	2.53e-05	CcSEcCtD
Ofloxacin—Vomiting—Prednisone—hematologic cancer	5.24e-06	2.52e-05	CcSEcCtD
Ofloxacin—ABCC1—Disease—CD80—hematologic cancer	5.22e-06	0.000129	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—KIT—hematologic cancer	5.21e-06	0.000129	CbGpPWpGaD
Ofloxacin—Rash—Prednisone—hematologic cancer	5.2e-06	2.5e-05	CcSEcCtD
Ofloxacin—Dermatitis—Prednisone—hematologic cancer	5.2e-06	2.5e-05	CcSEcCtD
Ofloxacin—ABCC1—Metabolism—MTHFR—hematologic cancer	5.19e-06	0.000128	CbGpPWpGaD
Ofloxacin—Decreased appetite—Doxorubicin—hematologic cancer	5.19e-06	2.5e-05	CcSEcCtD
Ofloxacin—Headache—Prednisone—hematologic cancer	5.17e-06	2.49e-05	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Doxorubicin—hematologic cancer	5.15e-06	2.48e-05	CcSEcCtD
Ofloxacin—Fatigue—Doxorubicin—hematologic cancer	5.15e-06	2.48e-05	CcSEcCtD
Ofloxacin—Urticaria—Epirubicin—hematologic cancer	5.13e-06	2.47e-05	CcSEcCtD
Ofloxacin—ABCC1—Disease—PTPN11—hematologic cancer	5.12e-06	0.000127	CbGpPWpGaD
Ofloxacin—Constipation—Doxorubicin—hematologic cancer	5.1e-06	2.46e-05	CcSEcCtD
Ofloxacin—Pain—Doxorubicin—hematologic cancer	5.1e-06	2.46e-05	CcSEcCtD
Ofloxacin—Abdominal pain—Epirubicin—hematologic cancer	5.1e-06	2.45e-05	CcSEcCtD
Ofloxacin—Body temperature increased—Epirubicin—hematologic cancer	5.1e-06	2.45e-05	CcSEcCtD
Ofloxacin—Hypersensitivity—Methotrexate—hematologic cancer	5.08e-06	2.44e-05	CcSEcCtD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	5.01e-06	0.000124	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ARNTL—hematologic cancer	4.99e-06	0.000124	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CREB1—hematologic cancer	4.96e-06	0.000123	CbGpPWpGaD
Ofloxacin—Asthenia—Methotrexate—hematologic cancer	4.95e-06	2.38e-05	CcSEcCtD
Ofloxacin—Feeling abnormal—Doxorubicin—hematologic cancer	4.92e-06	2.37e-05	CcSEcCtD
Ofloxacin—Nausea—Prednisone—hematologic cancer	4.9e-06	2.36e-05	CcSEcCtD
Ofloxacin—ABCC1—Disease—BRAF—hematologic cancer	4.89e-06	0.000121	CbGpPWpGaD
Ofloxacin—Gastrointestinal pain—Doxorubicin—hematologic cancer	4.88e-06	2.35e-05	CcSEcCtD
Ofloxacin—Pruritus—Methotrexate—hematologic cancer	4.88e-06	2.35e-05	CcSEcCtD
Ofloxacin—CYP1A2—Metabolism—ACP5—hematologic cancer	4.86e-06	0.00012	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CA9—hematologic cancer	4.86e-06	0.00012	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—IL6R—hematologic cancer	4.83e-06	0.00012	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CREBBP—hematologic cancer	4.83e-06	0.000119	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—NCOR2—hematologic cancer	4.79e-06	0.000119	CbGpPWpGaD
Ofloxacin—Hypersensitivity—Epirubicin—hematologic cancer	4.75e-06	2.29e-05	CcSEcCtD
Ofloxacin—Urticaria—Doxorubicin—hematologic cancer	4.74e-06	2.28e-05	CcSEcCtD
Ofloxacin—Abdominal pain—Doxorubicin—hematologic cancer	4.72e-06	2.27e-05	CcSEcCtD
Ofloxacin—Body temperature increased—Doxorubicin—hematologic cancer	4.72e-06	2.27e-05	CcSEcCtD
Ofloxacin—Diarrhoea—Methotrexate—hematologic cancer	4.72e-06	2.27e-05	CcSEcCtD
Ofloxacin—Asthenia—Epirubicin—hematologic cancer	4.63e-06	2.23e-05	CcSEcCtD
Ofloxacin—ABCC1—Disease—MAP2K1—hematologic cancer	4.61e-06	0.000114	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PIK3CD—hematologic cancer	4.58e-06	0.000113	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.57e-06	0.000113	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—IDH1—hematologic cancer	4.57e-06	0.000113	CbGpPWpGaD
Ofloxacin—Pruritus—Epirubicin—hematologic cancer	4.56e-06	2.2e-05	CcSEcCtD
Ofloxacin—Dizziness—Methotrexate—hematologic cancer	4.56e-06	2.19e-05	CcSEcCtD
Ofloxacin—CYP1A2—Metabolism—GSTO1—hematologic cancer	4.52e-06	0.000112	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ABCC3—hematologic cancer	4.52e-06	0.000112	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—TXN—hematologic cancer	4.52e-06	0.000112	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—SPHK1—hematologic cancer	4.42e-06	0.000109	CbGpPWpGaD
Ofloxacin—Diarrhoea—Epirubicin—hematologic cancer	4.41e-06	2.12e-05	CcSEcCtD
Ofloxacin—Hypersensitivity—Doxorubicin—hematologic cancer	4.4e-06	2.12e-05	CcSEcCtD
Ofloxacin—Vomiting—Methotrexate—hematologic cancer	4.38e-06	2.11e-05	CcSEcCtD
Ofloxacin—ABCC1—Disease—FGF2—hematologic cancer	4.38e-06	0.000108	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PIK3CG—hematologic cancer	4.36e-06	0.000108	CbGpPWpGaD
Ofloxacin—Rash—Methotrexate—hematologic cancer	4.35e-06	2.09e-05	CcSEcCtD
Ofloxacin—Dermatitis—Methotrexate—hematologic cancer	4.34e-06	2.09e-05	CcSEcCtD
Ofloxacin—ABCC1—Disease—PIK3R1—hematologic cancer	4.32e-06	0.000107	CbGpPWpGaD
Ofloxacin—Headache—Methotrexate—hematologic cancer	4.32e-06	2.08e-05	CcSEcCtD
Ofloxacin—Asthenia—Doxorubicin—hematologic cancer	4.28e-06	2.06e-05	CcSEcCtD
Ofloxacin—Dizziness—Epirubicin—hematologic cancer	4.27e-06	2.05e-05	CcSEcCtD
Ofloxacin—CYP1A2—Metabolism—UGT1A1—hematologic cancer	4.25e-06	0.000105	CbGpPWpGaD
Ofloxacin—Pruritus—Doxorubicin—hematologic cancer	4.22e-06	2.03e-05	CcSEcCtD
Ofloxacin—ABCC1—Disease—JAK2—hematologic cancer	4.2e-06	0.000104	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CRABP1—hematologic cancer	4.13e-06	0.000102	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—SLC22A1—hematologic cancer	4.13e-06	0.000102	CbGpPWpGaD
Ofloxacin—Vomiting—Epirubicin—hematologic cancer	4.1e-06	1.97e-05	CcSEcCtD
Ofloxacin—ABCC1—Disease—MDM2—hematologic cancer	4.1e-06	0.000101	CbGpPWpGaD
Ofloxacin—Nausea—Methotrexate—hematologic cancer	4.1e-06	1.97e-05	CcSEcCtD
Ofloxacin—Diarrhoea—Doxorubicin—hematologic cancer	4.08e-06	1.97e-05	CcSEcCtD
Ofloxacin—Rash—Epirubicin—hematologic cancer	4.07e-06	1.96e-05	CcSEcCtD
Ofloxacin—Dermatitis—Epirubicin—hematologic cancer	4.06e-06	1.96e-05	CcSEcCtD
Ofloxacin—ABCC1—Metabolism—CREBBP—hematologic cancer	4.04e-06	0.0001	CbGpPWpGaD
Ofloxacin—Headache—Epirubicin—hematologic cancer	4.04e-06	1.95e-05	CcSEcCtD
Ofloxacin—CYP1A2—Metabolism—ALOX5—hematologic cancer	4.02e-06	9.96e-05	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—MTOR—hematologic cancer	3.99e-06	9.87e-05	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PIK3CB—hematologic cancer	3.99e-06	9.87e-05	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CD4—hematologic cancer	3.98e-06	9.85e-05	CbGpPWpGaD
Ofloxacin—Dizziness—Doxorubicin—hematologic cancer	3.95e-06	1.9e-05	CcSEcCtD
Ofloxacin—CYP1A2—Metabolism—NUP98—hematologic cancer	3.9e-06	9.64e-05	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PIK3CD—hematologic cancer	3.83e-06	9.48e-05	CbGpPWpGaD
Ofloxacin—Nausea—Epirubicin—hematologic cancer	3.83e-06	1.84e-05	CcSEcCtD
Ofloxacin—Vomiting—Doxorubicin—hematologic cancer	3.8e-06	1.83e-05	CcSEcCtD
Ofloxacin—CYP1A2—Metabolism—ADCY7—hematologic cancer	3.78e-06	9.36e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—NCOA3—hematologic cancer	3.78e-06	9.36e-05	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ALB—hematologic cancer	3.78e-06	9.36e-05	CbGpPWpGaD
Ofloxacin—Rash—Doxorubicin—hematologic cancer	3.76e-06	1.81e-05	CcSEcCtD
Ofloxacin—Dermatitis—Doxorubicin—hematologic cancer	3.76e-06	1.81e-05	CcSEcCtD
Ofloxacin—CYP1A2—Metabolism—NUP214—hematologic cancer	3.76e-06	9.3e-05	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CDKN1B—hematologic cancer	3.74e-06	9.26e-05	CbGpPWpGaD
Ofloxacin—Headache—Doxorubicin—hematologic cancer	3.74e-06	1.8e-05	CcSEcCtD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	3.72e-06	9.2e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ABCG2—hematologic cancer	3.68e-06	9.11e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—MTR—hematologic cancer	3.68e-06	9.11e-05	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PIK3R1—hematologic cancer	3.62e-06	8.95e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ENO2—hematologic cancer	3.61e-06	8.93e-05	CbGpPWpGaD
Ofloxacin—Nausea—Doxorubicin—hematologic cancer	3.55e-06	1.71e-05	CcSEcCtD
Ofloxacin—CYP1A2—Metabolism—GSTT1—hematologic cancer	3.5e-06	8.66e-05	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CDKN1A—hematologic cancer	3.46e-06	8.55e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.45e-06	8.53e-05	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PTEN—hematologic cancer	3.45e-06	8.53e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—SDC1—hematologic cancer	3.42e-06	8.47e-05	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PIK3CB—hematologic cancer	3.34e-06	8.27e-05	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—EP300—hematologic cancer	3.29e-06	8.13e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.27e-06	8.09e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.23e-06	7.98e-05	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—SRC—hematologic cancer	3.2e-06	7.91e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.09e-06	7.64e-05	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—STAT3—hematologic cancer	3.08e-06	7.63e-05	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—NRAS—hematologic cancer	3.08e-06	7.61e-05	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—MAPK3—hematologic cancer	2.95e-06	7.29e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CD44—hematologic cancer	2.91e-06	7.2e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—NQO1—hematologic cancer	2.91e-06	7.2e-05	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PTEN—hematologic cancer	2.89e-06	7.14e-05	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—MYC—hematologic cancer	2.86e-06	7.09e-05	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—TGFB1—hematologic cancer	2.86e-06	7.07e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.85e-06	7.05e-05	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—EP300—hematologic cancer	2.75e-06	6.81e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CYCS—hematologic cancer	2.75e-06	6.81e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	2.74e-06	6.77e-05	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—KRAS—hematologic cancer	2.65e-06	6.55e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.46e-06	6.09e-05	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PIK3CA—hematologic cancer	2.43e-06	6.02e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GSTP1—hematologic cancer	2.43e-06	6e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.35e-06	5.81e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ABCB1—hematologic cancer	2.3e-06	5.68e-05	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—HRAS—hematologic cancer	2.25e-06	5.57e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GSTM1—hematologic cancer	2.23e-06	5.52e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—NCOR1—hematologic cancer	2.23e-06	5.52e-05	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—IL6—hematologic cancer	2.15e-06	5.33e-05	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PIK3CA—hematologic cancer	2.04e-06	5.04e-05	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—AKT1—hematologic cancer	1.99e-06	4.92e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—MTHFR—hematologic cancer	1.97e-06	4.88e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.74e-06	4.3e-05	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—AKT1—hematologic cancer	1.66e-06	4.12e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PIK3CG—hematologic cancer	1.66e-06	4.1e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CREBBP—hematologic cancer	1.54e-06	3.8e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1.46e-06	3.6e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ALB—hematologic cancer	1.44e-06	3.56e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PIK3R1—hematologic cancer	1.37e-06	3.4e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.27e-06	3.14e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PTEN—hematologic cancer	1.1e-06	2.71e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—EP300—hematologic cancer	1.05e-06	2.59e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PIK3CA—hematologic cancer	7.74e-07	1.91e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—AKT1—hematologic cancer	6.32e-07	1.56e-05	CbGpPWpGaD
